Chk Antibodies

Santa Cruz Biotechnology features a diverse variety of Chk Antibodies for the detection and analysis of checkpoint kinase proteins. Chk Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Checkpoint kinases, such as Chk1 and Chk2, regulate the DNA damage response and cell cycle progression, ensuring genomic stability and preventing the propagation of damaged DNA. Chk1 functions as a key mediator in the ATR-dependent checkpoint pathway, while Chk2 primarily responds to double-strand DNA breaks through the ATM pathway. Understanding checkpoint kinase activity provides crucial insights into cellular responses to DNA damage and replication stress. Researchers investigating cancer biology and therapeutic resistance rely on Chk1 and Chk2 detection for studying tumorigenesis mechanisms. The role of checkpoint kinases in cell cycle checkpoints makes them attractive targets for cancer therapy development. Chk Antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of cell cycle regulation and DNA damage response pathways.